1. The perfect mix: recent progress in adjuvant research;Guy;Nat Rev Microbiol,2007
2. GlaxoSmithKline adjuvant systems in vaccines: concepts, achievements and perspectives;Garçon;Expert Rev Vaccines,2007
3. Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies;Brennan;Vaccine,2005
4. European Medicines Agency: Committee for proprietary medicinal products (CPMP). Note for guidance on preclinical pharmacological and toxicological testing of vaccines; 1997. Report no.: CPMP/SWP/465/95. Available from: http://www.ema.europa.eu/pdfs/human/swp/046595en.pdf.
5. Food and Drug Administration (FDA): Center for Biologics Evaluation and Research (CBER). Guidance for Industry for the Evaluation of Combination Vaccines for Preventable Diseases: Production, Testing and Clinical Studies; 1997. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/UCM175909.pdf.